These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 8922756)

  • 1. Substantial excretion of digoxin via the intestinal mucosa and prevention of long-term digoxin accumulation in the brain by the mdr 1a P-glycoprotein.
    Mayer U; Wagenaar E; Beijnen JH; Smit JW; Meijer DK; van Asperen J; Borst P; Schinkel AH
    Br J Pharmacol; 1996 Nov; 119(5):1038-44. PubMed ID: 8922756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Full blockade of intestinal P-glycoprotein and extensive inhibition of blood-brain barrier P-glycoprotein by oral treatment of mice with PSC833.
    Mayer U; Wagenaar E; Dorobek B; Beijnen JH; Borst P; Schinkel AH
    J Clin Invest; 1997 Nov; 100(10):2430-6. PubMed ID: 9366556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of P-glycoprotein-mediated drug transport: A unifying mechanism to explain the interaction between digoxin and quinidine [seecomments].
    Fromm MF; Kim RB; Stein CM; Wilkinson GR; Roden DM
    Circulation; 1999 Feb; 99(4):552-7. PubMed ID: 9927403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transport and epithelial secretion of the cardiac glycoside, digoxin, by human intestinal epithelial (Caco-2) cells.
    Cavet ME; West M; Simmons NL
    Br J Pharmacol; 1996 Jul; 118(6):1389-96. PubMed ID: 8832062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine.
    Sparreboom A; van Asperen J; Mayer U; Schinkel AH; Smit JW; Meijer DK; Borst P; Nooijen WJ; Beijnen JH; van Tellingen O
    Proc Natl Acad Sci U S A; 1997 Mar; 94(5):2031-5. PubMed ID: 9050899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered drug disposition of the platelet activating factor antagonist apafant in mdr1a knockout mice.
    Leusch A; Volz A; Müller G; Wagner A; Sauer A; Greischel A; Roth W
    Eur J Pharm Sci; 2002 Aug; 16(3):119-28. PubMed ID: 12128165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute Effects of Viral Exposure on P-Glycoprotein Function in the Mouse Fetal Blood-Brain Barrier.
    Bloise E; Petropoulos S; Iqbal M; Kostaki A; Ortiga-Carvalho TM; Gibb W; Matthews SG
    Cell Physiol Biochem; 2017; 41(3):1044-1050. PubMed ID: 28222448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P-glycoprotein: a defense mechanism limiting oral bioavailability and CNS accumulation of drugs.
    Fromm MF
    Int J Clin Pharmacol Ther; 2000 Feb; 38(2):69-74. PubMed ID: 10706193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of the oral direct renin inhibitor aliskiren in combination with digoxin, atorvastatin, and ketoconazole in healthy subjects: the role of P-glycoprotein in the disposition of aliskiren.
    Vaidyanathan S; Camenisch G; Schuetz H; Reynolds C; Yeh CM; Bizot MN; Dieterich HA; Howard D; Dole WP
    J Clin Pharmacol; 2008 Nov; 48(11):1323-38. PubMed ID: 18784280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of ursodeoxycholic acid on P-glycoprotein and cytochrome P450 3A4-dependent pharmacokinetics in humans.
    Becquemont L; Glaeser H; Drescher S; Hitzl M; Simon N; Murdter TE; Heinkele G; Hofmann U; Schaefer C; Burk O; Verstuyft C; Eichelbaum M; Fromm MF
    Clin Pharmacol Ther; 2006 May; 79(5):449-60. PubMed ID: 16678547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of P-glycoprotein in limiting intestinal regional absorption of digoxin in rats.
    Sababi M; Borgå O; Hultkvist-Bengtsson U
    Eur J Pharm Sci; 2001 Aug; 14(1):21-7. PubMed ID: 11457646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic role of P-glycoprotein in oral bioavailability and intestinal secretion of grepafloxacin in vivo.
    Yamaguchi H; Yano I; Saito H; Inui K
    J Pharmacol Exp Ther; 2002 Mar; 300(3):1063-9. PubMed ID: 11861816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of interferon-gamma on the pharmacokinetics of digoxin, a P-glycoprotein substrate, intravenously injected into the mouse.
    Kawaguchi H; Matsui Y; Watanabe Y; Takakura Y
    J Pharmacol Exp Ther; 2004 Jan; 308(1):91-6. PubMed ID: 14569074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disposition of Delta tetrahydrocannabinol in CF1 mice deficient in mdr1a P-glycoprotein.
    Bonhomme-Faivre L; Benyamina A; Reynaud M; Farinotti R; Abbara C
    Addict Biol; 2008 Sep; 13(3-4):295-300. PubMed ID: 18331373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Montmorillonite-surfactant hybrid particles for modulating intestinal P-glycoprotein-mediated transport.
    Nielsen RB; Kahnt A; Dillen L; Wuyts K; Snoeys J; Nielsen UG; Holm R; Nielsen CU
    Int J Pharm; 2019 Nov; 571():118696. PubMed ID: 31525443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estradiol regulation of P-glycoprotein expression in mouse kidney and human tubular epithelial cells, implication for renal clearance of drugs.
    Kanado Y; Tsurudome Y; Omata Y; Yasukochi S; Kusunose N; Akamine T; Matsunaga N; Koyanagi S; Ohdo S
    Biochem Biophys Res Commun; 2019 Nov; 519(3):613-619. PubMed ID: 31540689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efavirenz does not interact with the ABCB1 transporter at the blood-brain barrier.
    Dirson G; Fernandez C; Hindlet P; Roux F; German-Fattal M; Gimenez F; Farinotti R
    Pharm Res; 2006 Jul; 23(7):1525-32. PubMed ID: 16779703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestinal P glycoprotein acts as a natural defense mechanism against Listeria monocytogenes.
    Neudeck BL; Loeb JM; Faith NG; Czuprynski CJ
    Infect Immun; 2004 Jul; 72(7):3849-54. PubMed ID: 15213126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ex vivo and in vivo investigations of the effects of extracts of Vernonia amygdalina, Carica papaya and Tapinanthus sessilifolius on digoxin transport and pharmacokinetics: assessing the significance on rat intestinal P-glycoprotein efflux.
    Oga EF; Sekine S; Horie T
    Drug Metab Pharmacokinet; 2013; 28(4):314-20. PubMed ID: 23291634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of digoxin-specific antibody fragments on digoxin disposition in the rat.
    Johnston PC; Stevenson IH; Hewick DS
    Biochem Pharmacol; 1987 Jul; 36(13):2215-20. PubMed ID: 3606637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.